MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617063400 A) filed by Dxlife Ab on May 19, 2026, for Methods And Polynucleotides And Uses Thereof.
Inventors include Lundberg Giwercman, Yvonne; and Nilsson, Mathilda Caroline.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The invention provides a method of stratifying a subject for treatment with human menopausal gonadotropins (hMG) or recombinant follicle-stimulating hormone (rFSH) comprising or consisting of the steps of: (a) providing a sample from a subject to be tested; (b) determining the follicle-stimulating hormone receptor (FSHR) N680S single nucleotide polymorphism (SNP) genotype of the subject; and (c) stratifying the subject for treatment with hMG if the genotype is homozygous for the 680S SNP; and stratifying the subject for treatment with rFSH if the genotype is homozygous N680 wild-type (WT); methods and uses for treating involuntary childlessness, infertility and for reducing the risk of ovarian hyperstimulation syndrome; and associated polynucleotide primers and kits for use in the same.
Disclaimer: Curated by HT Syndication.
